Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
(NASDAQ: PRLD) Delayed: 3.88 -0.11 (2.76%)
Previous Close $3.99    52 Week High $ 
Open $4.00    52 Week Low $ 
Day High $4.05    P/E N/A 
Day Low $3.83    EPS $ 
Volume 336,232